The Virtual Human Platform was developed using three case studies based on human scenarios.
For each case study, two regulatory questions were defined to demonstrate how the platform supports step-by-step safety assessment. Within the Safety Assessment Steps, users can access the tools, methods, and data needed to address these regulatory questions. These steps organize the platform’s processes, guiding users through structured, transparent assessments. For more information, visit our Safety Assessment Steps info page.
To study kidney disease and pharmacovigilance.
To study life course pesticide exposure and neurodegenerative disease.
To study health effects discriminated by age and sex on thyroid-mediated neurodevelopment.